---
title: "Aspen Neuroscience Awards Executive Chair Faheem Hasnain 321,672 Restricted Stock Units"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/304917788.md"
description: "Aspen Neuroscience Executive Chair Faheim Hasnain was awarded 321,672 restricted stock units (common stock shares) on November 5, 2026. The information was published via EDGAR by Aspen Neuroscience Inc. on November 9, 2026."
datetime: "2026-11-09T22:16:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/304917788.md)
  - [en](https://longbridge.com/en/news/304917788.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/304917788.md)
generator: "portal-rs"
---

# Aspen Neuroscience Awards Executive Chair Faheem Hasnain 321,672 Restricted Stock Units

-   Aspen Neuroscience Executive Chair Faheem Hasnain reported a common stock award of 321,672 shares dated Nov. 5, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspen Neuroscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-453834), on November 09, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ASPE.US](https://longbridge.com/en/quote/ASPE.US.md)

## Related News & Research

- [ARCH Venture Partners X Discloses 12.9% Stake in Aspen Neuroscience](https://longbridge.com/en/news/304929595.md)
- [Aspen Neuroscience's Amended Bylaws Take Effect at IPO Closing](https://longbridge.com/en/news/304014788.md)
- [Lumentum President and CEO Michael E. Hurlston Reports Disposal of $4.48 Million in Common Shares](https://longbridge.com/en/news/305879399.md)
- [OrbiMed Advisors Discloses Investment at Aspen Neuroscience, Inc. with 12.3% Stake](https://longbridge.com/en/news/304700413.md)
- [OrbiMed Advisors reports acquisition of $15 million in Aspen Neuroscience common shares](https://longbridge.com/en/news/304354913.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**